This is a serious illness that happens after someone gets a large dose of radiation all at once, like from a nuclear accident. It can cause feeling sick, like loss of appetite, nausea, and vomiting. If it gets worse, it can affect many parts of the body, including the blood, stomach, nerves, and lungs.
Every report comes from a Lived member, sent anonymously.
Have you tried Neupogen (Filgrastim) for Acute Radiation Syndrome?
Acute radiation syndrome (ARS), often called radiation sickness, is a serious illness that follows a very large dose of radiation to most of the body over a short period, usually minutes. The radiation damages cells that divide quickly, especially in the bone marrow, which makes blood cells, and in the lining of the gut. How sick a person becomes depends mainly on how much radiation the body absorbed. ARS tends to unfold in stages. Nausea, vomiting and loss of appetite can begin within minutes to days of exposure. These early symptoms may then fade, and the person can look and feel generally well for a few hours to a few weeks. That calm period is misleading: it is often followed by the main illness, when falling blood counts, gut damage or both cause serious problems. People then either recover gradually or, after the highest doses, may die within days to months.
ARS is caused only by a large dose of penetrating radiation (such as gamma rays, high-energy X-rays or neutrons) reaching the whole body, or most of it, in a short time. Situations that can do this include nuclear or radiological accidents, a nuclear detonation, and rare industrial or laboratory accidents. Routine X-rays, CT (computed tomography) scans and the low-level background radiation everyone receives deliver far smaller doses and do not cause ARS. Radiation therapy for cancer is usually given in many small doses aimed at one area, which makes ARS much less likely, although it has its own side effects. Doctors measure absorbed radiation in grays (Gy). Symptoms of ARS generally appear above about 0.7 Gy. Between roughly 0.7 and 10 Gy the bone marrow is mainly affected; above about 10 Gy severe gut damage adds to the illness, and above about 50 Gy the heart, blood vessels and brain are overwhelmed within hours. The closer someone was to the source and the longer they stayed, the higher the dose. A developing baby, children, older adults and people with weakened immune systems are more vulnerable to radiation's effects.
No single sign or symptom proves ARS, so diagnosis starts with the story of the exposure: what kind of radiation it was, how far the person was from the source and for how long. Specialists may also use radiation detection equipment to check for contamination on the skin or clothing. The timing of symptoms helps estimate the dose. In general, the sooner vomiting begins after exposure, the higher the dose is likely to have been, although stress and many other causes can also produce vomiting. Repeated blood counts are especially informative. Lymphocytes, a type of white blood cell, are very sensitive to radiation, and a fast drop over the first one to two days points to a larger dose. In some cases a specialized laboratory examines chromosomes in blood cells to refine the estimate. These measurements guide how intensive treatment needs to be.
Treatment focuses on supporting the body while damaged tissues try to recover. That means protecting against infection when white blood cell counts are low (with isolation precautions and antibiotics or other anti-infection medicines), replacing fluids lost to vomiting and diarrhea, controlling nausea, and treating any burns or injuries. Transfusions of platelets or red blood cells may be needed when counts fall too far. Contamination is removed from the skin, and some people receive medicines that help remove radioactive material taken into the body. For the bone marrow form of ARS, the US Food and Drug Administration (FDA) has approved several growth factor medicines that stimulate the marrow to make blood cells and improve the chance of survival: filgrastim (Neupogen), pegfilgrastim (Neulasta) and sargramostim (Leukine), which boost infection-fighting white cells, and romiplostim (Nplate), which supports platelets. Because studies in people exposed to such doses are not possible, these approvals rest mainly on animal research, and they work best when started early. When the marrow is unlikely to recover on its own, a stem cell transplant may be considered at a specialized center. Treatment can do far less once the gut or nervous system has been severely damaged.
The outlook depends heavily on the dose. People who received lower doses often recover, though the process can take several weeks and up to two years, with fatigue and a period of low blood counts along the way. As the dose rises, survival becomes less likely: roughly half of people exposed to about 2.5 to 5 Gy would die within 60 days without medical care, and survival after the gut form is extremely unlikely. Skilled supportive care improves the odds. Skin damage commonly accompanies ARS. It can include redness, blistering, slow-healing wounds and hair loss, which may be permanent after very large skin doses. Survivors have a higher long-term risk of cancer and usually need ongoing follow-up with their care team. Living through a radiation emergency is also stressful, and support for anxiety or grief can be an important part of recovery.
After a radiation emergency, follow official instructions about sheltering and where to go for screening, and tell the clinicians who assess you where you were and for how long. Anyone who may have received a significant dose needs emergency medical evaluation, especially if nausea or vomiting starts in the hours afterward, even if those symptoms then settle. For someone recovering from known exposure, fever, signs of infection or unusual bleeding or bruising call for contacting the care team right away, because these can signal falling blood counts.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Acute Radiation Syndrome is like, what's helped you, or ask the community a question.